Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
WELLSKIN Barriere Silicone Skin Cream is an over-the-counter 20% silicone (dimethicone) topical barrier cream developed for the prevention and treatment of diaper rash, adult incontinence-associated dermatitis, chapped or cracked skin, and irritation from detergents and other harsh skin irritants. The formulation uses a high concentration of silicone as an occlusive skin protectant that forms a breathable, water‑resistant film over the epidermis to repel moisture, reduce friction, and seal out irritants while helping to retain skin hydration.[1][2][7][10] It is marketed primarily in Canada in multiple pack sizes for use on sensitive skin areas, and is positioned as non‑greasy, non‑toxic, and suitable for frequent application in infants, adults, and seniors.[1][2][5][10]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on WELLSKIN Barriere Silicone Skin Cream.